Analytical Reviews

Forexmart's analytical reviews provide up-to-date technical information about the financial market. These reports range from stock trends, to financial forecasts, to global economy reports, and political news that impact the market.

Disclaimer:  Information provided here to retail and professional clients does not contain and should not be construed as containing investment advice or an investment recommendation or an offer or solicitation to engage in any transaction or strategy in financial instruments. Past performance is not a guarantee or prediction of future performance.

Trumpův návrh zákona o výdajích pravděpodobně zvýší náklady pojišťoven a omezí pokrytí Medicaid

Návrh zákona prezidenta Donalda Trumpa o výdajích podle odborníků zvýší administrativní náklady a zkomplikuje správu nákladů pojišťovnám, jako jsou UnitedHealthcare a Aetna (NYSE:CVS) společnosti CVS Health, které provozují zdravotní plány Medicaid.

V důsledku toho tyto pojišťovny pravděpodobně omezí pokrytí Medicaid a budou více investovat do stávajících trhů, aby si udržely zdravější členy, uvedli odborníci.

Státy uzavírají smlouvy s pojišťovnami, včetně UnitedHealthcare společnosti UnitedHealth Group (NYSE:UNH), Aetna společnosti CVS Health, Centene (NYSE:CNC) a Molina, na provozování programů Medicaid, které jsou společně financovány státními a federálními vládami.

Téměř veškerá pojišťovací činnost společnosti Molina a téměř polovina pojišťovací činnosti společnosti Centene tvoří členové Medicaid. Tento podíl je menší u společností Aetna a UnitedHealthcare, které provozují velké komerční podniky.

Sedm odborníků z oboru tvrdí, že škrty v financování návrhu zákona a jeho ustanovení, které vyžaduje, aby státy ověřovaly pracovní status pacientů, jsou pro pojišťovny tvrdou ranou.

Ustanovení v Trumpově návrhu zákona One Big Beautiful Bill Act vyžaduje, aby dospělí s nízkými příjmy ve státech, které rozšířily pokrytí Medicaid v rámci zákona Affordable Care Act, každých šest měsíců prokazovali, že splňují pracovní požadavky, aby si mohli zachovat pojištění.

Pět odborníků z oboru uvedlo, že státní úřady Medicaid, které se potýkají s nedostatkem pracovníků, budou mít potíže s prováděním ověřovacích protokolů.

„Očekává se, že státy budou muset být připraveny do roku 2026 nebo 2027, což je velmi krátká doba,“ uvedla Nikita Singareddy, generální ředitelka zdravotnické platformy Fortuna Health.

Nasdaq beats expectations: revenue +15% to $1.5bn
01:24 2026-07-24 UTC--4

Nasdaq shares jumped by 2.0% in pre-market trade after the company released its quarterly report, beating analyst expectations for revenue and earnings, recording double-digit growth across key lines and announcing a cash dividend.

The report released today confirmed Nasdaq's business resilience despite a weaker broad market.

Adjusted EPS came in at $1.07, well above consensus of roughly $0.97–$0.98. Net revenue reached $1.5bn, up 15% year-on-year and exceeding analysts' estimates.

By segment, the company posted record results. Capital Access Platforms generated $621m in revenue, up 19% year-on-year.

The fintech segment produced $539m, up 16%. The index business was particularly strong, with revenue rising by 38% y/y to $271m, supported by growth in assets under management in Nasdaq-branded ETF products and the high-profile inclusion of SpaceX in the Nasdaq 100 in early July.

analytics6a62190f7615a.jpg

The board declared a quarterly cash dividend of $0.31 per share, payable on 25 September 2026, underscoring management's commitment to shareholder returns. Analysts were supportive before the print: TD Cowen raised its price target from $101 to $105, while Goldman Sachs and RBC Capital maintained positive ratings.

Nasdaq stock gain stands out against an unfavourable macro backdrop: the S&P 500 is down about 1.05%, the Dow Jones is off 1.17%, and the Nasdaq Composite is down roughly 1.56% in pre-market trade.

Pressure on the market stems from disappointing results at other large tech names, geopolitical tensions, and lingering uncertainty over the Fed's monetary policy path.

Peers such as Intercontinental Exchange and CME Group are also facing these crosswinds, so today's outperformance is a Nasdaq story rather than an industry-wide phenomenon.

What it means: an earnings beat, confident double-digit growth across all three business segments, stable dividends, and analyst support combined to push Nasdaq shares sharply higher despite the broad market retreat, reinforcing investor confidence in the company's diversified revenue model and its growing role as a global fintech platform.

コメントする

ForexMart is authorized and regulated in various jurisdictions.

(Reg No.23071, IBC 2015) with a registered office at First Floor, SVG Teachers Co-operative Credit Union Limited Uptown Building, Corner of James and Middle Street, Kingstown, Saint Vincent and the Grenadines

Restricted Regions: the United States of America, North Korea, Sudan, Syria and some other regions.


aWS
© 2015-2026 Tradomart SV Ltd.
Top Top
Risk Warning:
Foreign exchange is highly speculative and complex in nature, and may not be suitable for all investors. Forex trading may result in a substantial gain or loss. Therefore, it is not advisable to invest money you cannot afford to lose. Before using the services offered by ForexMart, please acknowledge the risks associated with forex trading. Seek independent financial advice if necessary. Please note that neither past performance nor forecasts are reliable indicators of future results.
Foreign exchange is highly speculative and complex in nature, and may not be suitable for all investors. Forex trading may result in a substantial gain or loss. Therefore, it is not advisable to invest money you cannot afford to lose. Before using the services offered by ForexMart, please acknowledge the risks associated with forex trading. Seek independent financial advice if necessary. Please note that neither past performance nor forecasts are reliable indicators of future results.